Active	Status	Sponsor type	Region	Phase	Filter
10 Active 5 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kamphuisen, Pieter W
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)	Recruiting	3	12500	Europe, Canada, Japan, US, RoW	Lepodisiran Sodium, LY3819469, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)	03/29	03/29
Bemmel, T van
DARE, NCT05669547: Dual Hormone Closed Loop in Type 1 Diabetes	Recruiting	N/A	240	Europe	dual hormone fully closed loop (DHFCL), Inreda AP (Inreda Diabetic BV)	UMC Utrecht, Dutch National Health Care Institute, Inreda Diabetic B.V.	Diabetes Mellitus, Type 1, Diabetes type1, Diabetes	10/25	01/26
Seebus, E
DARE, NCT05669547: Dual Hormone Closed Loop in Type 1 Diabetes	Recruiting	N/A	240	Europe	dual hormone fully closed loop (DHFCL), Inreda AP (Inreda Diabetic BV)	UMC Utrecht, Dutch National Health Care Institute, Inreda Diabetic B.V.	Diabetes Mellitus, Type 1, Diabetes type1, Diabetes	10/25	01/26
Ziekenhuis, Tergooi
DARE, NCT05669547: Dual Hormone Closed Loop in Type 1 Diabetes	Recruiting	N/A	240	Europe	dual hormone fully closed loop (DHFCL), Inreda AP (Inreda Diabetic BV)	UMC Utrecht, Dutch National Health Care Institute, Inreda Diabetic B.V.	Diabetes Mellitus, Type 1, Diabetes type1, Diabetes	10/25	01/26
Scheffer, Mirjam
No trials found
Kosterink-Brackel, Caroline
No trials found